Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2023 ∙ Feng, S. McLellan, J. Pidduck, N. Roberts, N. Higgins, J. P. T. Choi, Y. Izu, A. Jit, M. Madhi, S. A. Mulholland, K. Pollard, A. J. Temple, B. Voysey, M.
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Low
2023 ∙ Addario, A. Célarier, T. Bongue, B. Barth, N. Gavazzi, G. Botelho-Nevers, E.
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review
Older adults Influenza Pneumococcal disease Herpes zoster Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Patel, J. Noureldin, M. Fakhouri, D. Farraye, F. A. Kovar-Gough, I. Warren, B. Waljee, A. K. Piper, M. S.
Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2023 ∙ Geraghty, K. Rooney, D. Watson, C. Ledwidge, M. T. Glynn, L. Gallagher, J.
Non-specific effects of Pneumococcal and Haemophilus vaccines in children aged 5 years and under: a systematic review
Newborn Children Pneumococcal disease Haemophilus influenzae type B Efficacy/effectiveness
Rating:
Low
2023 ∙ Arya, S. Norton, N. Kaushik, P. Brandtmuller, A. Tsoumani, E.
Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature
Europe Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2023 ∙ Farrar, J. L. Childs, L. Ouattara, M. Akhter, F. Britton, A. Pilishvili, T. Kobayashi, M.
Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
Americas United States of America Adolescents Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Reyburn, Rita Tsatsaronis, Anthea von Mollendorf, Claire Mulholland, Kim Russell, Fiona M. Duke T, Graham H. Graham S. Gray A. Gwee A. von Mollendorf C. Mulholland K. Russell F. Hume-Nixon M. Kazi S. Kevat P. Neal E. Nguyen C. Quach A. Reyburn R. Ryan K. Walker P. Wilkes C. Chua P. Nisar Y. B. Simon J. Were W. A. R. I. Review group
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2023 ∙ van Heuvel, L. Paget, J. Dückers, M. Caini, S.
The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis
All age groups Influenza Pneumococcal disease COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Reyburn, Rita Maher, Jaclyn von Mollendorf, Claire Gwee, Amanda Mulholland, Kim Russell, Fiona Duke T, Graham H. Graham S. Gray A. Hume-Nixon M. Kazi S. Kevat P. Neal E. Nguyen C. Quach A. Ryan K. Walker P. Wilkes C. Chua P. Nisar Y. B. Simon J. Were W. A. R. I. Review group
The impact of the introduction of ten- or thirteen-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal disease and carriage: A systematic literature review
All age groups Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2023 ∙ Gowrishankar, S. V. Fleet, A. Tomasoni, M. Durham, R. Umeria, R. Merchant, S. A. Shah, S. F. H. Muzaffar, J. Mohammed, H. Kuhn, I. Tysome, J. Smith, M. E. Donnelly, N. Axon, P. Bance, M. Borsetto, D.
The Risk of Meningitis After Cochlear Implantation: A Systematic Review and Meta-Analysis
All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Low
Loading...